Novel Decellularization Method for Tissue Slices.

biocompatibility bioscaffold recellularization decellularization extracellular matrix lung tissue slices

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2022
Historique:
received: 09 12 2021
accepted: 09 02 2022
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 1 4 2022
Statut: epublish

Résumé

Decellularization procedures have been developed and optimized for the entire organ or tissue blocks, by either perfusion of decellularizing agents through the tissue's vasculature or submerging large sections in decellularizing solutions. However, some research aims require the analysis of native as well as decellularized tissue slices side by side, but an optimal protocol has not yet been established to address this need. Thus, the main goal of this work was to develop a fast and efficient decellularization method for tissue slices-with an emphasis on lung-while attached to a glass slide. To this end, different decellularizing agents were compared for their effectiveness in cellular removal while preserving the extracellular matrix. The intensity of DNA staining was taken as an indicator of remaining cells and compared to untreated sections. The presence of collagen, elastin and laminin were quantified using immunostaining and signal quantification. Scaffolds resulting from the optimized protocol were mechanically characterized using atomic force microscopy. Lung scaffolds were recellularized with mesenchymal stromal cells to assess their biocompatibility. Some decellularization agents (CHAPS, triton, and ammonia hydroxide) did not achieve sufficient cell removal. Sodium dodecyl sulfate (SDS) was effective in cell removal (1% remaining DNA signal), but its sharp reduction of elastin signal (only 6% remained) plus lower attachment ratio (32%) singled out sodium deoxycholate (SD) as the optimal treatment for this application (6.5% remaining DNA signal), due to its higher elastin retention (34%) and higher attachment ratio (60%). Laminin and collagen were fully preserved in all treatments. The SD decellularization protocol was also successful for porcine and murine (mice and rat) lungs as well as for other tissues such as the heart, kidney, and bladder. No significant mechanical differences were found before and after sample decellularization. The resulting acellular lung scaffolds were shown to be biocompatible (98% cell survival after 72 h of culture). This novel method to decellularize tissue slices opens up new methodological possibilities to better understand the role of the extracellular matrix in the context of several diseases as well as tissue engineering research and can be easily adapted for scarce samples like clinical biopsies.

Identifiants

pubmed: 35356779
doi: 10.3389/fbioe.2022.832178
pii: 832178
pmc: PMC8959585
doi:

Types de publication

Journal Article

Langues

eng

Pagination

832178

Informations de copyright

Copyright © 2022 Narciso, Ulldemolins, Júnior, Otero, Navajas, Farré, Gavara and Almendros.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Liver Int. 2013 Mar;33(3):448-58
pubmed: 23301992
Regen Ther. 2019 May 10;11:8-16
pubmed: 31193142
Biotechniques. 2016 Oct 1;61(4):206-209
pubmed: 27712584
J Struct Biol. 2003 Sep;143(3):201-8
pubmed: 14572475
Integr Biol (Camb). 2015 Dec;7(12):1598-610
pubmed: 26426090
Biomed Res Int. 2017;2017:9831534
pubmed: 28540307
Eur Respir J. 2017 Jul 5;50(1):
pubmed: 28679607
Biomaterials. 2013 Sep;34(28):6638-48
pubmed: 23727263
Nat Commun. 2019 Oct 11;10(1):4620
pubmed: 31604958
Acta Biomater. 2017 Mar 1;50:207-219
pubmed: 27993639
Front Med (Lausanne). 2021 Apr 16;8:610189
pubmed: 33937276
Int J Mol Sci. 2021 Nov 29;22(23):
pubmed: 34884731
J Histochem Cytochem. 2019 Jun;67(6):441-452
pubmed: 30694090
Mater Sci Eng C Mater Biol Appl. 2020 Dec;117:111311
pubmed: 32919672
Nanotechnology. 2013 Feb 8;24(5):055102
pubmed: 23324556
Mol Cell Proteomics. 2015 Apr;14(4):961-73
pubmed: 25660013
Acta Biomater. 2011 Mar;7(3):1241-8
pubmed: 21094703
Int J Mol Sci. 2021 Aug 05;22(16):
pubmed: 34445106
Surg Today. 2020 Jul;50(7):633-643
pubmed: 32363425
Reprod Biol Endocrinol. 2020 Jul 23;18(1):75
pubmed: 32703228
Biomaterials. 2013 Apr;34(13):3231-45
pubmed: 23380353
Int J Mol Sci. 2020 Jul 30;21(15):
pubmed: 32751654
Biochim Biophys Acta. 2014 Aug;1840(8):2506-19
pubmed: 24418517
Dis Model Mech. 2011 Mar;4(2):165-78
pubmed: 21324931
Integr Biol (Camb). 2015 Dec;7(12):1518-25
pubmed: 26563425
Ann Thorac Surg. 2013 Sep;96(3):1046-55; discussion 1055-6
pubmed: 23870827
PLoS One. 2017 Jun 1;12(6):e0178696
pubmed: 28570606
Biomaterials. 2016 May;89:114-26
pubmed: 26963901
J Mech Behav Biomed Mater. 2015 Sep;49:69-79
pubmed: 26002417
Int J Mol Sci. 2019 Aug 17;20(16):
pubmed: 31426504
J Cell Physiol. 2017 Jan;232(1):19-26
pubmed: 27163411
J Biomed Mater Res A. 2016 Aug;104(8):1922-35
pubmed: 27012815
Sci Rep. 2018 Apr 3;8(1):5409
pubmed: 29615673
Acta Biomater. 2016 Dec;46:91-100
pubmed: 27693690
Acta Biomater. 2017 Apr 15;53:268-278
pubmed: 28161576
PLoS One. 2014 Jul 29;9(7):e103672
pubmed: 25072252
Cold Spring Harb Perspect Biol. 2012 Jan 01;4(1):a004903
pubmed: 21937732
Polymers (Basel). 2021 Jul 18;13(14):
pubmed: 34301107
Acta Biomater. 2019 Jul 1;92:265-276
pubmed: 31085362
Sci Adv. 2020 Oct 21;6(43):
pubmed: 33087348
Acta Biomater. 2014 Dec;10(12):5043-5054
pubmed: 25173840

Auteurs

Maria Narciso (M)

Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
The Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Anna Ulldemolins (A)

Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.

Constança Júnior (C)

Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
The Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Jorge Otero (J)

Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
The Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.
CIBER de Enfermedades Respiratorias, Madrid, Spain.

Daniel Navajas (D)

Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
The Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.
CIBER de Enfermedades Respiratorias, Madrid, Spain.

Ramon Farré (R)

Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
CIBER de Enfermedades Respiratorias, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Núria Gavara (N)

Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
The Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Isaac Almendros (I)

Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
CIBER de Enfermedades Respiratorias, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Classifications MeSH